Báo cáo y học: "First isolation of two colistin-resistant emerging pathogens, Brevundimonas diminuta and Ochrobactrum anthropi, in a woman with cystic fibrosis: a case report"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: First isolation of two colistin-resistant emerging pathogens, Brevundimonas diminuta and Ochrobactrum anthropi, in a woman with cystic fibrosis: a case report | Journal of Medical Case Reports BioMed Central Open Access First isolation of two colistin-resistant emerging pathogens Brevundimonas diminuta and Ochrobactrum anthropi in a woman with cystic fibrosis a case report Magalie Menuet1 Fadi Bittar1 Nathalie Stremler2 Jean-Christophe Dubus2 Jacques Sarles2 Didier Raoult1 and Jean-Marc Rolain 1 Address 1URMITE UMR 6236 CNRS-IRD Faculté de Médecine et de Pharmacie Bd Jean Moulin 13385 Marseille cedex 05 France and 2Département des Maladies respiratoires centre de Ressources et de compétences pour la Mucoviscidose Enfants CRCM Hôpital Timone Marseille France Email Magalie Menuet - Fadi Bittar - bittar_fadi@ Nathalie Stremler - Jean-Christophe Dubus - Jacques Sarles - Didier Raoult - Jean-Marc Rolain - Corresponding author Published 5 December 2008 Received II October 2007 Journal of Medical Case Reports 2008 2 373 doi 1752-1947-2-373 Accepted 5 December 2008 This article is available from http content 2 1 373 2008 Menuet et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Introduction Cystic fibrosis afflicted lungs support the growth of many bacteria rarely implicated in other cases of human infections. Case presentation We report the isolation and identification by 16S rRNA amplification and sequencing of two emerging pathogens resistant to colistin Brevundimonas diminuta and Ochrobactrum anthropi in a 17-year-old woman with cystic fibrosis and pneumonia. The patient eventually responded well to a 2-week regime of imipenem and tobramycin. Conclusion Our results .

Bấm vào đây để xem trước nội dung
TÀI LIỆU LIÊN QUAN
TÀI LIỆU MỚI ĐĂNG
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.